The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
Abstract
A new mathematical model was used to analyze a detailed set of human immunodeficiency virus-type 1 (HIV-1) viral load data collected from five infected individuals after the administration of a potent inhibitor of HIV-1 protease. Productively infected cells were estimated to have, on average, a life-span of 2.2 days (half-life t 1/2 = 1.6 days), and plasma virions were estimated to have a mean life-span of 0.3 days ( t 1/2 = 0.24 days). The estimated average total HIV-1 production was 10.3 × 10 9 virions per day, which is substantially greater than previous minimum estimates. The results also suggest that the minimum duration of the HIV-1 life cycle in vivo is 1.2 days on average, and that the average HIV-1 generation time—defined as the time from release of a virion until it infects another cell and causes the release of a new generation of viral particles—is 2.6 days. These findings on viral dynamics provide not only a kinetic picture of HIV-1 pathogenesis, but also theoretical principles to guide the development of treatment strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efron, B., & Tibshirani, R. (1986) · Statistical Science · doi:10.1214/ss/1177013815 · Cited by 6,033
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M., & Markowitz, M. (1995) · Nature · doi:10.1038/373123a0 · Cited by 4,267
Self-citationViral dynamics in human immunodeficiency virus type 1 infection
Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Deutsch, P., Lifson, J. D., Bonhoeffer, S., Nowak, M. A., Hahn, B. H., et al. (1995) · Nature · doi:10.1038/373117a0 · Cited by 3,260
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
Coffin, J. M. (1995) · Science · doi:10.1126/science.7824947 · Cited by 1,981
Mansky, L. M., & Temin, H. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.5087-5094.1995 · Cited by 1,154
Quantitation of Human Immunodeficiency Virus Type 1 in the Blood of Infected Persons
Ho, D. D., Moudgil, T., & Alam, M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912143212401 · Cited by 1,064
Self-citationKempf, D. J., Marsh, K. C., Denissen, J. F., McDonald, E., Vasavanonda, S., Flentge, C. A., Green, B. E., Fino, L., Park, C. H., & Kong, X. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2484 · Cited by 560
A Preliminary Study of Ritonavir, an Inhibitor of HIV-1 Protease, to Treat HIV-1 Infection
Markowitz, M., Saag, M., Powderly, W. G., Hurley, A. M., Hsu, A., Valdes, J. M., Henry, D., Sattler, F., Marca, A. L., Leonard, J. M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512073332204 · Cited by 493
Self-citationTime to Hit HIV, Early and Hard
Ho, D. D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508173330710 · Cited by 431
Self-citationCarmichael, A., Jin, X., Sissons, P., & Borysiewicz, L. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.249 · Cited by 418
Cited by
Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma
Mellors, J. W., Rinaldo, C. R., Gupta, P., White, R. M., Todd, J. A., & Kingsley, L. A. (1996) · Science · doi:10.1126/science.272.5265.1167 · Cited by 2,660
Finzi, D., Blankson, J., Siliciano, J. D., Margolick, J. B., Chadwick, K., Pierson, T., Smith, K., Lisziewicz, J., Lori, F., Flexner, C., et al. (1999) · Nature Medicine · doi:10.1038/8394 · Cited by 2,119
Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy
Neumann, A. U., Lam, N. P., Dahari, H., Gretch, D. R., Wiley, T. E., Layden, T. J., & Perelson, A. S. (1998) · Science · doi:10.1126/science.282.5386.103 · Cited by 2,113
Self-citationQuantification of latent tissue reservoirs and total body viral load in HIV-1 infection
Chun, T.-W., Carruth, L., Finzi, D., Shen, X., DiGiuseppe, J. A., Taylor, H., Hermankova, M., Chadwick, K., Margolick, J., Quinn, T. C., et al. (1997) · Nature · doi:10.1038/387183a0 · Cited by 2,050
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
Chun, T.-W., Stuyver, L., Mizell, S. B., Ehler, L. A., Mican, J. A. M., Baseler, M., Lloyd, A. L., Nowak, M. A., & Fauci, A. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13193 · Cited by 1,977
Decay characteristics of HIV-1-infected compartments during combination therapy
Perelson, A. S., Essunger, P., Cao, Y., Vesanen, M., Hurley, A., Saksela, K., Markowitz, M., & Ho, D. D. (1997) · Nature · doi:10.1038/387188a0 · Cited by 1,880
Self-citationMathematical Analysis of HIV-1 Dynamics in Vivo
Perelson, A. S., & Nelson, P. W. (1999) · SIAM Review · doi:10.1137/s0036144598335107 · Cited by 1,552
Self-citationJin, X., Bauer, D. E., Tuttleton, S. E., Lewin, S., Gettie, A., Blanchard, J., Irwin, C. E., Safrit, J. T., Mittler, J., Weinberger, L., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.6.991 · Cited by 1,407
Self-citationUnifying the Epidemiological and Evolutionary Dynamics of Pathogens
Grenfell, B. T., Pybus, O. G., Gog, J. R., Wood, J. L. N., Daly, J. M., Mumford, J. A., & Holmes, E. C. (2004) · Science · doi:10.1126/science.1090727 · Cited by 1,385
Borrow, P., Lewicki, H., Wei, X., Horwitz, M. S., Peffer, N., Meyers, H., Nelson, J. A., Gairin, J. E., Hahn, B. H., Oldstone, M. B. A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-205 · Cited by 1,183
Gazzard, B., & on behalf of the BHIVA Treatment Guidelines Writing Group (2008) · HIV Medicine · doi:10.1111/j.1468-1293.2008.00636.x · Cited by 1,089
Viral dynamics in hepatitis B virus infection.
Nowak, M. A., Bonhoeffer, S., Hill, A. M., Boehme, R., Thomas, H. C., & McDade, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4398 · Cited by 1,045
Timing the ancestor of the HIV-1 pandemic strains.
Korber, B., Muldoon, M., Theiler, J., Gao, F., Gupta, R., Lapedes, A., Hahn, B. H., Wolinsky, S., & Bhattacharya, T. (2000) · Science · doi:10.1126/science.288.5472.1789 · Cited by 1,021
Domingo, E., Sheldon, J., & Perales, C. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05023-11 · Cited by 1,009
Carpenter, C. C. J., Fischl, M. A., Hammer, S. M., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., Montaner, J. S. G., Richman, D. D., Saag, M. S., Schooley, R. T., et al. (1998) · JAMA · doi:10.1001/jama.280.1.78 · Cited by 995
Kilby, J. M., Hopkins, S., Venetta, T. M., DiMassimo, B., Cloud, G. A., Lee, J. Y., Alldredge, L., Hunter, E., Lambert, D., Bolognesi, D., et al. (1998) · Nature Medicine · doi:10.1038/3293 · Cited by 987
Modelling viral and immune system dynamics
Perelson, A. S. (2002) · Nature Reviews Immunology · doi:10.1038/nri700 · Cited by 955
Self-citationFlexner, C. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804303381808 · Cited by 852
HIV-1 Antiretroviral Drug Therapy
Arts, E. J., & Hazuda, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007161 · Cited by 851
Host factors and the pathogenesis of HIV-induced disease
Fauci, A. S. (1996) · Nature · doi:10.1038/384529a0 · Cited by 829
Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral Therapy
Zhang, L., Ramratnam, B., Tenner-Racz, K., He, Y., Vesanen, M., Lewin, S., Talal, A., Racz, P., Perelson, A. S., Korber, B. T., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905273402101 · Cited by 807
Self-citationClavel, F., & Hance, A. J. (2004) · New England Journal of Medicine · doi:10.1056/nejm2ra025195 · Cited by 800
Ordered accumulation of mutations in HIV protease confers resistance to ritonavir
Molla, A., Korneyeva, M., Gao, Q., Vasavanonda, S., Schipper, P. J., Mo, H.-M., Markowitz, M., Chernyavskiy, T., Niu, P., Lyons, N., et al. (1996) · Nature Medicine · doi:10.1038/nm0796-760 · Cited by 762
Self-citationKinetics of Influenza A Virus Infection in Humans
Baccam, P., Beauchemin, C., Macken, C. A., Hayden, F. G., & Perelson, A. S. (2006) · Journal of Virology · doi:10.1128/jvi.01623-05 · Cited by 756
Self-citationCarpenter, C. C. J. (1997) · JAMA · doi:10.1001/jama.1997.03540480062040 · Cited by 725
Qin, X.-F., An, D. S., Chen, I. S. Y., & Baltimore, D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232688199 · Cited by 701
Pakker, N. G., Notermans, D. W., De Boer, R. J., Roos, M. T. L., Wolf, F. D., Hill, A., Leonard, J. M., Danner, S. A., Miedema, F., & Schellekens, P. T. A. (1998) · Nature Medicine · doi:10.1038/nm0298-208 · Cited by 701
Self-citationRates of Molecular Evolution in RNA Viruses: A Quantitative Phylogenetic Analysis
Jenkins, G. M., Rambaut, A., Pybus, O. G., & Holmes, E. C. (2002) · Journal of Molecular Evolution · doi:10.1007/s00239-001-0064-3 · Cited by 692
Modeling infectious disease dynamics in the complex landscape of global health
Heesterbeek, H., Anderson, R. M., Andreasen, V., Bansal, S., De Angelis, D., Dye, C., Eames, K. T. D., Edmunds, W. J., Frost, S. D. W., Funk, S., et al. (2015) · Science · doi:10.1126/science.aaa4339 · Cited by 690
Janssen, R. S. (1998) · JAMA · doi:10.1001/jama.280.1.42 · Cited by 687
Guidelines for the use of antiretroviral agents in pediatric HIV infection: (477722008-001)
(2008) · PsycEXTRA Dataset · doi:10.1037/e477722008-001 · Cited by 670
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
Palmer, S., Maldarelli, F., Wiegand, A., Bernstein, B., Hanna, G. J., Brun, S. C., Kempf, D. J., Mellors, J. W., Coffin, J. M., & King, M. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800050105 · Cited by 638
The Challenge of HIV-1 Subtype Diversity
Taylor, B. S., Sobieszczyk, M. E., McCutchan, F. E., & Hammer, S. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0706737 · Cited by 635
Virus dynamics and drug therapy
Bonhoeffer, S., May, R. M., Shaw, G. M., & Nowak, M. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6971 · Cited by 632
Weinberger, L. S., Burnett, J. C., Toettcher, J. E., Arkin, A. P., & Schaffer, D. V. (2005) · Cell · doi:10.1016/j.cell.2005.06.006 · Cited by 630
The Challenge of Viral Reservoirs in HIV-1 Infection
Blankson, J. N., Persaud, D., & Siliciano, R. F. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104024 · Cited by 627
Kinetics of Response in Lymphoid Tissues to Antiretroviral Therapy of HIV-1 Infection
Cavert, W., Notermans, D. W., Staskus, K., Wietgrefe, S. W., Zupancic, M., Gebhard, K., Henry, K., Zhang, Z.-Q., Mills, R., McDade, H., et al. (1997) · Science · doi:10.1126/science.276.5314.960 · Cited by 622
Furtado, M. R., Callaway, D. S., Phair, J. P., Kunstman, K. J., Stanton, J. L., Macken, C. A., Perelson, A. S., & Wolinsky, S. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905273402102 · Cited by 611
Self-citationQuantitative Image Analysis of HIV-1 Infection in Lymphoid Tissue
Haase, A. T., Henry, K., Zupancic, M., Sedgewick, G., Faust, R. A., Melroe, H., Cavert, W., Gebhard, K., Staskus, K., Zhang, Z.-Q., et al. (1996) · Science · doi:10.1126/science.274.5289.985 · Cited by 599
Self-citationDynamics analysis of a delayed virus model with two different transmission methods and treatments
Zhang, T., Wang, J., Li, Y., Jiang, Z., & Han, X. (2020) · Advances in Difference Equations · doi:10.1186/s13662-019-2438-0 · Cited by 582
Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant
Persaud, D., Gay, H., Ziemniak, C., Chen, Y. H., Piatak, M., Chun, T.-W., Strain, M., Richman, D., & Luzuriaga, K. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302976 · Cited by 581
Perelson, A. S., & Weisbuch, G. (1997) · Reviews of Modern Physics · doi:10.1103/revmodphys.69.1219 · Cited by 574
Self-citationThe causes and consequences of HIV evolution
Rambaut, A., Posada, D., Crandall, K. A., & Holmes, E. C. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1246 · Cited by 564
Hirsch, M. S., Conway, B., D'Aquila, R. T., Johnson, V. A., Brun-Vézinet, F., Clotet, B., Demeter, L. M., Hammer, S. M., Jacobsen, D. M., Kuritzkes, D. R., et al. (1998) · JAMA · doi:10.1001/jama.279.24.1984 · Cited by 563
Haase, A. T. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.625 · Cited by 548
Pierson, T., McArthur, J., & Siliciano, R. F. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.665 · Cited by 545
Macrophages as a Source of HIV During Opportunistic Infections
Orenstein, J. M., Fox, C., & Wahl, S. M. (1997) · Science · doi:10.1126/science.276.5320.1857 · Cited by 525
HIV viral load markers in clinical practice
Saag, M. S., Holodniy, M., Kuritzkes, D. R., O'Brien, W. A., Coombs, R., Poscher, M. E., Jacobsen, D. M., Shaw, G. M., Richman, D. D., & Volberding, P. A. (1996) · Nature Medicine · doi:10.1038/nm0696-625 · Cited by 524
Goh, W. C., Rogel, M. E., Kinsey, C. M., Michael, S. F., Fultz, P. N., Nowak, M. A., Hahn, B. H., & Emerman, M. (1998) · Nature Medicine · doi:10.1038/nm0198-065 · Cited by 518
(2002) · PsycEXTRA Dataset · doi:10.1037/e548362006-001 · Cited by 517
Modeling Plasma Virus Concentration during Primary HIV Infection
STAFFORD, M. A., COREY, L., CAO, Y., DAAR, E. S., HO, D. D., & PERELSON, A. S. (2000) · Journal of Theoretical Biology · doi:10.1006/jtbi.2000.1076 · Cited by 487
Self-citationRitonavir: Clinical Pharmacokinetics and Interactions with Other Anti-HIV Agents
Hsu, A., Granneman, G. R., & Bertz, R. J. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199835040-00002 · Cited by 483
Ramratnam, B., Bonhoeffer, S., Binley, J., Hurley, A., Zhang, L., Mittler, J. E., Markowitz, M., Moore, J. P., Perelson, A. S., & Ho, D. D. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02035-8 · Cited by 481
Self-citationRedefining the Viral Reservoirs that Prevent HIV-1 Eradication
Eisele, E., & Siliciano, R. F. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.010 · Cited by 474
“Because the halflife of plasma virus is on the order of minutes (Perelson et al., 1996; Ramratnam et al., 1999), this low-level viremia, referred to as ‘‘residual viremia,’’ indicates ongoing virus production in patients on HAART.”
BackgroundStructural biology of HIV 1 1Edited by P. E. Wright
Turner, B. G., & Summers, M. F. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2354 · Cited by 470
Mathematical analysis of delay differential equation models of HIV-1 infection
Nelson, P. W., & Perelson, A. S. (2002) · Mathematical Biosciences · doi:10.1016/s0025-5564(02)00099-8 · Cited by 463
Self-citationThe power of a good idea: Quantitative modeling of the spread of ideas from epidemiological models
Bettencourt, L. M. A., Cintrón-Arias, A., Kaiser, D. I., & Castillo-Chávez, C. (2006) · Physica A: Statistical Mechanics and its Applications · doi:10.1016/j.physa.2005.08.083 · Cited by 463
Ramratnam, B., Mittler, J. E., Zhang, L., Boden, D., Hurley, A., Fang, F., Macken, C. A., Perelson, A. S., Markowitz, M., & Ho, D. D. (2000) · Nature Medicine · doi:10.1038/71577 · Cited by 452
Self-citationCD4+ T-cell depletion in HIV infection: Are we closer to understanding the cause?
Grossman, Z., Meier-Schellersheim, M., Sousa, A. E., Victorino, R. M. M., & Paul, W. E. (2002) · Nature Medicine · doi:10.1038/nm0402-319 · Cited by 450
Kelleher, A. D., Long, C., Holmes, E. C., Allen, R. L., Wilson, J., Conlon, C., Workman, C., Shaunak, S., Olson, K., Goulder, P., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.3.375 · Cited by 448
Dinoso, J. B., Kim, S. Y., Wiegand, A. M., Palmer, S. E., Gange, S. J., Cranmer, L., O'Shea, A., Callender, M., Spivak, A., Brennan, T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903107106 · Cited by 441
Chen, P., Hübner, W., Spinelli, M. A., & Chen, B. K. (2007) · Journal of Virology · doi:10.1128/jvi.00381-07 · Cited by 440
Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay.
Herz, A. V., Bonhoeffer, S., Anderson, R. M., May, R. M., & Nowak, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7247 · Cited by 440
Sharkey, M. E., Teo, I., Greenough, T., Sharova, N., Luzuriaga, K., Sullivan, J. L., Bucy, R. P., Kostrikis, L. G., Haase, A., Veryard, C., et al. (2000) · Nature Medicine · doi:10.1038/71569 · Cited by 428
Cytokine Signals Are Sufficient for HIV-1 Infection of Resting Human T Lymphocytes
Unutmaz, D., KewalRamani, V. N., Marmon, S., & Littman, D. R. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1735 · Cited by 427
“It is also tempting to speculate that cytokine-mediated bystander activation of resting T cells may facilitate the spread of the virus in vivo, thus contributing to the rapid viral turnover rates (70, 71).”
BackgroundConsiderations in the Evaluation of Surrogate Endpoints in Clinical Trials
De Gruttola, V. G., Clax, P., DeMets, D. L., Downing, G. J., Ellenberg, S. S., Friedman, L., Gail, M. H., Prentice, R., Wittes, J., & Zeger, S. L. (2001) · Controlled Clinical Trials · doi:10.1016/s0197-2456(01)00153-2 · Cited by 427
Richman, D. D. (2001) · Nature · doi:10.1038/35073673 · Cited by 419
Kempf, D. J., Marsh, K. C., Kumar, G., Rodrigues, A. D., Denissen, J. F., McDonald, E., Kukulka, M. J., Hsu, A., Granneman, G. R., Baroldi, P. A., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.3.654 · Cited by 417
Self-citationMarkowitz, M., Nguyen, B.-Y., Gotuzzo, E., Mendo, F., Ratanasuwan, W., Kovacs, C., Prada, G., Morales-Ramirez, J. O., Crumpacker, C. S., Isaacs, R. D., et al. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318157131c · Cited by 408
Self-citationHepatitis C in the HIV-Infected Person
Sulkowski, M. S., & Thomas, D. L. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-3-200302040-00012 · Cited by 405
HIV-1 Infection and Low Steady State Viral Loads
Callaway, D. (2002) · Bulletin of Mathematical Biology · doi:10.1006/bulm.2001.0266 · Cited by 402
de Béthune, M.-P. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.09.008 · Cited by 401
Markowitz, M., Louie, M., Hurley, A., Sun, E., Di Mascio, M., Perelson, A. S., & Ho, D. D. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.5037-5038.2003 · Cited by 399
Self-citationReplicative Fitness of Protease Inhibitor-Resistant Mutants of Human Immunodeficiency Virus Type 1
Martinez-Picado, J., Savara, A. V., Sutton, L., & D’Aquila, R. T. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3744-3752.1999 · Cited by 396
A model of HIV-1 pathogenesis that includes an intracellular delay
Nelson, P. W., Murray, J. D., & Perelson, A. S. (2000) · Mathematical Biosciences · doi:10.1016/s0025-5564(99)00055-3 · Cited by 393
Self-citationHertogs, K., de Béthune, M.-P., Miller, V., Ivens, T., Schel, P., Van Cauwenberge, A., Van den Eynde, C., van Gerwen, V., Azijn, H., van Houtte, M., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.269 · Cited by 389
HIV-1 Regulatory/Accessory Genes: Keys to Unraveling Viral and Host Cell Biology
Emerman, M., & Malim, M. H. (1998) · Science · doi:10.1126/science.280.5371.1880 · Cited by 386
Mathematical and Computational Challenges in Population Biology and Ecosystems Science
Levin, S. A., Grenfell, B., Hastings, A., & Perelson, A. S. (1997) · Science · doi:10.1126/science.275.5298.334 · Cited by 382
Self-citationMechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS
Alimonti, J. B., Ball, T. B., & Fowke, K. R. (2003) · Journal of General Virology · doi:10.1099/vir.0.19110-0 · Cited by 374
Target Cell Limited and Immune Control Models of HIV Infection: A Comparison
De Boer, R. J., & Perelson, A. S. (1998) · Journal of Theoretical Biology · doi:10.1006/jtbi.1997.0548 · Cited by 371
Self-citationSelective CXCR4 antagonism by Tat: Implications for in vivo expansion of coreceptor use by HIV-1
Xiao, H., Neuveut, C., Tiffany, H. L., Benkirane, M., Rich, E. A., Murphy, P. M., & Jeang, K.-T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.21.11466 · Cited by 368
Nijhuis, M., Schuurman, R., de Jong, D., Erickson, J., Gustchina, E., Albert, J., Schipper, P., Gulnik, S., & Boucher, C. A. B. (1999) · AIDS · doi:10.1097/00002030-199912030-00006 · Cited by 367
Rapid Turnover of T Lymphocytes in SIV-Infected Rhesus Macaques
Mohri, H., Bonhoeffer, S., Monard, S., Perelson, A. S., & Ho, D. D. (1998) · Science · doi:10.1126/science.279.5354.1223 · Cited by 366
Self-citationAccurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID
Jabara, C. B., Jones, C. D., Roach, J., Anderson, J. A., & Swanstrom, R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110064108 · Cited by 365
Induction of HIV-1 Replication in Latently Infected CD4+ T Cells Using a Combination of Cytokines
Chun, T.-W., Engel, D., Mizell, S. B., Ehler, L. A., & Fauci, A. S. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.1.83 · Cited by 359
Gao, F., Robertson, D. L., Morrison, S. G., Hui, H., Craig, S., Decker, J., Fultz, P. N., Girard, M., Shaw, G. M., Hahn, B. H., et al. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.7013-7029.1996 · Cited by 358
De Clercq, E. (1998) · Antiviral Research · doi:10.1016/s0166-3542(98)00025-4 · Cited by 358
Increased Turnover of T Lymphocytes in HIV-1 Infection and Its Reduction by Antiretroviral Therapy
Mohri, H., Perelson, A. S., Tung, K., Ribeiro, R. M., Ramratnam, B., Markowitz, M., Kost, R., Hurley, Weinberger, L., Cesar, D., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.9.1277 · Cited by 358
Self-citationLethal mutagenesis of HIV with mutagenic nucleoside analogs
Loeb, L. A., Essigmann, J. M., Kazazi, F., Zhang, J., Rose, K. D., & Mullins, J. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1492 · Cited by 357
Human Immunodeficiency Virus (HIV)
German Advisory Committee Blood (Arbeitskreis Blut), S. ‘. O. P. T. B. B. (2016) · Transfusion Medicine and Hemotherapy · doi:10.1159/000445852 · Cited by 355
Frost, S. D. W., Wrin, T., Smith, D. M., Pond, S. L. K., Liu, Y., Paxinos, E., Chappey, C., Galovich, J., Beauchaine, J., Petropoulos, C. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504658102 · Cited by 353
A biologist's guide to mathematical modeling in ecology and evolution
(2007) · Choice Reviews Online · doi:10.5860/choice.44-6894 · Cited by 350
Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest
Stewart, S. A., Poon, B., Jowett, J. B., & Chen, I. S. (1997) · Journal of Virology · doi:10.1128/jvi.71.7.5579-5592.1997 · Cited by 350
Lässig, M., Mustonen, V., & Walczak, A. M. (2017) · Nature Ecology & Evolution · doi:10.1038/s41559-017-0077 · Cited by 343
Latent reservoirs of HIV: Obstacles to the eradication of virus
Chun, T.-W., & Fauci, A. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.10958 · Cited by 342
Yang, O. O., Kalams, S. A., Trocha, A., Cao, H., Luster, A., Johnson, R. P., & Walker, B. D. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.3120-3128.1997 · Cited by 340
Craigie, R., & Bushman, F. D. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006890 · Cited by 327
Functional mapping — how to map and study the genetic architecture of dynamic complex traits
Wu, R., & Lin, M. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1804 · Cited by 334
ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia
Maldarelli, F., Palmer, S., King, M. S., Wiegand, A., Polis, M. A., Mican, J., Kovacs, J. A., Davey, R. T., Rock-Kress, D., Dewar, R., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030046 · Cited by 333
Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa
Lam, N. P., Neumann, A. U., Gretch, D. R., Wiley, T. E., Perelson, A. S., & Layden, T. J. (1997) · Hepatology · doi:10.1002/hep.510260130 · Cited by 329
Self-citation
Metadata
- Authors
- Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M., & Ho, D. D.
- Venue
- Science
- Published
- 1996-03-15
- Volume
- 271
- Issue
- 5255
- Pages
- 1582-1586
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2022098233
- Cited by
- 3,531
- References
- 13
- FWCI
- 53.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.